Home › NDC Lookup › RxCUI directory › RxCUI 1719764

Eluxadoline 100 MG Oral Tablet — RxCUI 1719764

RxNorm drug concept · Semantic clinical drug
RxCUI 1719764 Semantic clinical drug · SCD ● Current RxNorm concept 2 FDA products 4 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1719764
Official nameEluxadoline 100 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped2
Package NDCs mapped4
Reported Medicaid activity (SDUD)7,211 prescriptions · 31 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Eluxadoline: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Viberzi targets opioid receptors in your intestine — not in your brain — to help slow down gut contractions and reduce pain signals. The result is fewer episodes of diarrhea and le...
  • What exactly does Viberzi do for my IBS-D?
  • No — this is one of the most important safety points with Viberzi. If you no longer have a gallbladder, you should not take this medication at all. People without a gallbladder fac...
  • Is it safe to take Viberzi if I've had my gallbladder out?
📖 Read our full Eluxadoline guide →

🕸️ Concept Web — How Eluxadoline 100 MG Oral Tablet Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Eluxadoline 100 MG Oral Tablet RxCUI 1719764

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Eluxadoline 1653781
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Viberzi 1653787
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Eluxadoline Oral Tablet 1653785
    • Eluxadoline Oral Product 1653783
    • Eluxadoline Pill 1653784
    • Eluxadoline Oral Tablet [Viberzi] 1653789
    • Viberzi Oral Product 1653790
    • Viberzi Pill 1653791
    • Oral Tablet 317541
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Eluxadoline 100 MG SCDC · 1719763
  • Eluxadoline Oral Tablet SCDF · 1653785
  • Eluxadoline Oral Product SCDG · 1653783
  • Eluxadoline Pill SCDG · 1653784

Brand-Name Concepts

  • Eluxadoline 100 MG Oral Tablet [Viberzi] SBD · 1719766
  • Eluxadoline 100 MG [Viberzi] SBDC · 1719765
  • Eluxadoline Oral Tablet [Viberzi] SBDF · 1653789
  • Viberzi Oral Product SBDG · 1653790
  • Viberzi Pill SBDG · 1653791
  • Viberzi BN · 1653787

📦 FDA Products & Package NDCs

2 products · 4 package NDCs
4 package NDCs map to RxCUI 1719764 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
61874-0075-16 2 BLISTER PACK in 1 CARTON (61874-075-16) / 8 TABLET, FILM... Viberzi Allergan, Inc. 2026-01-01
61874-0075-60 1 BOTTLE in 1 CARTON (61874-075-60) / 60 TABLET, FILM COATE... Viberzi Allergan, Inc. 2015-10-01
61874-0100-16 2 BLISTER PACK in 1 CARTON (61874-100-16) / 8 TABLET, FILM... Viberzi Allergan, Inc. 2025-09-01
61874-0100-60 1 BOTTLE in 1 CARTON (61874-100-60) / 60 TABLET, FILM COATE... Viberzi Allergan, Inc. 2015-10-01
Observed labelers: Allergan, Inc. (4) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.